PHP
APYX icon

Parkman Healthcare Partners’s Apyx Medical APYX Stock Holding History

Parkman Healthcare Partners’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-70,497
Closed -$391K – 86
2020
Q2 		$391K Buy
70,497
+35,000
+99% +$145K 0.11% 77
2020
Q1 		$127K Buy
35,497
+102
+0.3% +$685 0.06% 65
2019
Q4 		$299K Buy
+35,395
New +$256K 0.09% 69

Other funds holding APYX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Parkman Healthcare Partners's APYX Position: Q3 2020 in Review

Parkman Healthcare Partners sold out of Apyx Medical (APYX) in Q3 2020, closing a stake of 70,497 shares — an estimated $391K sold.

Parkman Healthcare Partners first reported a position in APYX in Q4 2019 and held it in 3 quarters. The position peaked at $391K in Q2 2020. 61 funds tracked by Wall St. Rank hold APYX as of Q3 2020.

  • Parkman Healthcare Partners reported no remaining Apyx Medical position as of Q3 2020 after selling out during the quarter.
  • Parkman Healthcare Partners sold 70,497 Apyx Medical shares in Q3 2020, an estimated $391K.
  • Parkman Healthcare Partners first reported a position in Apyx Medical in Q4 2019 and held it in 3 quarters.
  • Parkman Healthcare Partners's Apyx Medical position peaked at $391K in Q2 2020.
  • 61 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2020.

Based on Parkman Healthcare Partners's 13F filing for Q3 2020, filed 13 Nov 2020.